Immunic, Inc.

NASDAQ:IMUX

Biotechnology

Healthcare
$7.39 -0.28%

-$0.04 today

Market cap
$100.83M
Beta
1.39
P/E (TTM)
-4.1
EPS (TTM)
-$3.46
52W Low $5.06High $15.77

Volume 0.39M

Average 0.27M

Balance Sheet

Inspect the capital base behind the business.

Assets

$24.05M

FY 2025 · Annual

-41.1% YoY

Liabilities

$30.73M

FY 2025 · Annual

+36.9% YoY

Equity

-$6.67M

FY 2025 · Annual

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents86.86M106.75M46.67M35.67M15.48M
Short-term Investments09.63M000
Net Receivables2.15M296K703K684K4.12M
Inventory05.61M000
Other Current Assets1.12M3.59M2.84M1.11M1.2M
Total Current Assets104.99M125.86M52.53M39.33M22.87M
Property, Plant & Equipment (Net)1.1M1.85M1.77M1.54M1.18M
Goodwill32.97M0000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets42K43K000
Total Non-current Assets34.11M1.89M1.77M1.54M1.18M
Total Assets139.1M127.75M54.3M40.87M24.05M
Account Payables3.5M4.28M5.1M7.85M10.14M
Short-term Debt0000470K
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities851K7.34M17.48M676K20.01M
Total Current Liabilities11.4M13.08M24.73M22.18M30.62M
Long-term Debt0000107K
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities0000(107K)
Total Non-current Liabilities584K992K639K264K107K
Total Liabilities11.99M14.07M25.37M22.44M30.73M
Common Stock3K4K4K8K9K
Retained Earnings(196.87M)(317.28M)(410.89M)(511.4M)(608.57M)
Accumulated OCI(252K)3.04M3.76M4.21M2.65M
Other Stockholders Equity00000
Minority Interest00000
Total Equity127.12M113.68M28.93M18.43M(6.67M)
Total Debt992K1.56M1.33M1M684K
Net Debt(85.87M)(105.18M)(45.34M)(34.66M)(14.8M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$186.6M
Receivables$354.0K
Other Current$1.8M
Total Current Assets$188.8M
PP&E (Net)$983.0K
Total Non-current Assets$983.0K
Total Assets$189.7M

Analysis

Selected assets total $189.7M for Latest. The largest visible component is Cash & Equivalents at $186.6M, about 98.4% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13GSC 13G filingNov 13, 2026
10-QQuarterly reportNov 13, 2026
8-KCurrent reportNov 13, 2026
8-KCurrent reportNov 5, 2026
SC 13G/ASC 13G/A filingNov 2, 2026

How much cash does IMUX have?

Immunic, Inc. (IMUX) reported $15.48M in cash and equivalents in fiscal 2025.

How much debt does IMUX carry?

Immunic, Inc. (IMUX) reported $684,000.00 of total debt, with net debt of -$14.80M.